eMerge Genetics - Non GMO SoyBean Seeds

Dow AgroSciences, Schillinger Seed Announces Licensing, R&D Agreement on Soybean Genetics

03/03/2009

Corey Nikkel
cnikkel@schillingerseed.com
515-225-1166

Dow AgroSciences, Schillinger Seed Announces Licensing, R&D
Agreement on Soybean Genetics

 
INDIANAPOLIS and WEST DES MOINES – March 3, 2009 – Dow
AgroSciences LLC and Schillinger Seed, Inc. have entered into a licensing,
research and development agreement for the commercialization of transgenic
commodity soybeans. 


“We are pleased to be working with Schillinger. This is one more step to expand
the soybean genetic platform for Dow AgroSciences, and will expand the
soybean platform for Dow AgroSciences to launch its Dow Herbicide Tolerance
(DHT) trait,” said Jerome Peribere, president and CEO, Dow AgroSciences.
“Furthermore, this collaboration will help accelerate the development and launch
of future traits in soybeans.”
 
Under the agreement, Dow AgroSciences will obtain the Schillinger Seed brand
and exclusive right to breed, produce, distribute and sell Schillinger Seed brand
transgenic commodity soybeans. In addition Schillinger will continue to develop
and produce proprietary soybean germplasm for Dow AgroSciences to use in
breeding and commercial sales. 
 
Non-GMO and specialty soybeans will continue to be researched, developed and
marketed independently by Schillinger under its recently introduced eMerge
Genetics™ brand. 
 
“This is a ‘win-win’ for both sides,” said John Schillinger, president and CEO for
Schillinger Seed, Inc. “This agreement really allows us to focus on developing
and marketing specialty soybeans for the food and feed industry under our eMerge                                                        Genetics™ brand, where we have seen tremendous growth opportunities recently.”
 
Dow AgroSciences will continue to sell Schillinger Seed transgenic soybean seed
through Stratton Seed of Stuttgart, Ark., in the Southern U.S. Additional terms of
the agreement were not disclosed.


About Schillinger Seed
Schillinger Seed and eMerge Genetics™ were founded by soybean seed
industry veteran John Schillinger, former president of Asgrow Seed. The
company recently launched an elite, premium soybean brand exclusively
dedicated to non-GMO soybeans. More information about eMerge Genetics™
can be found at www.eMergeGenetics.com.


About Dow AgroSciences
Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier
agricultural company that combines the power of science and technology with the
"Human Element" to constantly improve what is essential to human progress.
Dow AgroSciences provides innovative technologies for crop protection, pest and
vegetation management, seeds, traits, and agricultural biotechnology to serve
the world's growing population. Global sales for Dow AgroSciences, a wholly
owned subsidiary of The Dow Chemical Company, were $4.5 billion in 2008.
Learn more at www.dowagro.com 

 

eMerge Genetics™ is a registered trademark of Schillinger Seed Inc.
 

Non-GMO Perspectives

I had a 120 acre field of Schillinger 388 beans that I was extremely pleased with. It was just a real tough spring for us with our soybean planting. Everything was late and fields were wet and I had weed control problems in some areas and had to do some late spraying in spots. Even in the areas where the beans were run over they were running 55 bushels on my monitor and in the clean area the monitor was hitting 75 bushels. Overall, they were the best yielding beans I had on my farm outyielding any RR beans I had this year. I will definitely plant most of my farm next year with Schillinger non-GMO and I am looking forward to the contract opportunities in my area for non-GMO.

Tim Engnell
Non GMO Grower from Pattison, IA